How does a blood disorder drug perform in everyday practice?
NCT ID NCT07681440
First seen Jul 02, 2026 · Last updated Jul 02, 2026
Summary
This study looks at how the drug luspatercept is used in real-world clinics for patients with lower-risk myelodysplastic syndromes (MDS) or beta-thalassemia. Researchers will track patient characteristics, treatments, and outcomes like reduced need for blood transfusions. The goal is to understand the drug's effectiveness and costs outside of strict clinical trial settings.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
luspatercept
What this could lead to
If successful, this could help doctors understand how luspatercept works outside of clinical trials, potentially improving treatment guidelines for these blood disorders.
What could go wrong
This is an observational study, not a controlled trial, so it cannot prove cause and effect. Results may be limited by small size and real-world data variability.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MYELODYSPLASTIC SYNDROMES are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Early Check Newborn Screening Study (NCT03655223)
- Age-Adapted Busulfan Regimens for MDS Transplant NCT07677306
- Carolina Senior Registry for Older Cancer Patien NCT01137825
- Cousin vs Sibling Donors for Stem Cell Transplan NCT07662382
- Automated TMLI for HCT in High-Risk Myeloid Canc NCT07634536
- Selinisole Combo for TP53-Mutated Myeloid Tumors NCT07632170
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
ZEG Berlin, Center for Epidemiology and Health Research
Berlin, Germany